EFMH
PCVX icon

E Fund Management (HK)’s Vaxcyte PCVX Stock Holding History

E Fund Management (HK)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1K Buy
328
+85
+35% +$4.62K 0.01% 325
2026
Q1 		$14.1K Buy
+243
New +$13.2K 0.01% 276

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

E Fund Management (HK)'s PCVX Position: Q2 2026 in Review

E Fund Management (HK) increased its Vaxcyte (PCVX) stake by 35% in Q2 2026, buying an estimated $4.62K and bringing the position to 328 shares worth $19.1K. The position accounts for 0.01% of the portfolio, ranked #325.

E Fund Management (HK) first reported a position in PCVX in Q1 2026 and has held it in 2 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • E Fund Management (HK) held 328 shares of Vaxcyte worth $19.1K as of Q2 2026.
  • E Fund Management (HK) bought 85 Vaxcyte shares in Q2 2026, an estimated $4.62K.
  • Vaxcyte made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #325 holding.
  • E Fund Management (HK) first reported a position in Vaxcyte in Q1 2026 and has held it in 2 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.